THE STOCK IS88.8%AWAY FROM ALL-TIME HIGHS OF$42.81 RXRX IS DOWN-29%SINCE THE BEGINNING OF THE YEAR RXRX IS DOWN-46%OVER THE PAST 12 MONTHS RXRX IS DOWN-27%OVER THE PAST 1 MONTH 28%OF ALL RXRX INVESTORS ARE BETTING AGAINST RXRX ...
The stock has since dropped $0.01 in after-hours trading.About RXRX Insights Learn Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion...
RX | Complete BioSyent Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Lexicon Pharmaceuticals started at buy with $21 stock price target at Citigroup Aug. 2, 2016 at 8:33 a.m. ETby Tomi Kilgore Lexicon's stock soars after drug pact with Sanofi Nov. 6, 2015 at 1:19 p.m. ETby Ezequiel Minaya
A high-level overview of Lexicon Pharmaceuticals, Inc. (LXRX) stock. View (LXRX) real-time stock price, chart, news, analysis, analyst reviews and more.
$RXRXwhen are we expecting data release from some other their trials? I thought they had like 15-20 active trials? Good data results should move the stock.Bullish WallStreetBuyDipMar 16, 2025 7:53 AM Result summaries are very crucial to keep track of how the strategy is going. Here's...
The bid & ask refers to the price that an investor is willing to buy or sell a stock. The bid is the highest amount that a buyer is currently willing to pay, whereas the ask is the lowest amount that a seller is currently willing to sell. The numbers next to the bi...
Recursion Pharmaceuticals Inc-A 估值:11.00 2月6日Gil Blum - Needham 对Recursion Pharmaceuticals Inc-A(RXRX)给出Buy评级,并给出$11.00目标价格。 00 转发(0)评论(0)站内推送 Scott Schoenhaus01/09 Recursion Pharmaceuticals Inc-A 估值:10.00
Sell Nvidia, buy Broadcom! What is the mark 09:36 美股量子计算:泡沫还是未来? 21:01 US Stock Quantum Computing: Bubble or Future? 09:22 ASIC崛起挑战GPU霸主地位深度剖析与展望 09:49 Why the Dow Jones Fell for 9 Days Straight! 11:18 道指十连跌背后美国经济韧性对Fed货币政策及股市类...
Barchart provides Analyst Ratings to give you another tool to gauge the possible future performance of a stock. Analyst Ratings are available for US and Canadian equities. Unlike Barchart Opinions (which calculate the Buy/Sell rating using a variety of short-medium and long-term technical ...